Guidelines of the International Headache Society for Controlled Clinical Trials in Idiopathic Intracranial Hypertension

Susan P. Mollan, Clare L. Fraser, Kathleen B. Digre, Hans Christoph Diener, Richard B. Lipton, Marianne Juhler, Neil R. Miller, Patricia Pozo-Rosich, Mansoureh Togha, Kristian Brock, Marc J. Dinkin, Carmen K.M. Chan, Cristina Tassorelli, Alex J. Sinclair, Gisela M. Terwindt, Rigmor H. Jensen

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

The quality of clinical trials is essential to advance treatment, inform regulatory decisions and meta-analysis. With the increased incidence of idiopathic intracranial hypertension and the emergence of clinical trials for novel therapies in this condition, the International Headache Society Guidelines for Controlled Clinical Trials in Idiopathic Intracranial Hypertension aims to establish guidelines for designing state-of-the-art controlled clinical trials for idiopathic intracranial hypertension.

Original languageEnglish (US)
JournalCephalalgia
Volume43
Issue number8
DOIs
StatePublished - Aug 2023

Keywords

  • Guidelines
  • Idiopathic intracranial hypertension
  • Pseudotumor cerebri
  • Randomised control trial
  • drug
  • headache
  • lumbar puncture
  • papilloedema
  • raised intracranial pressure
  • vision

ASJC Scopus subject areas

  • Clinical Neurology

Fingerprint

Dive into the research topics of 'Guidelines of the International Headache Society for Controlled Clinical Trials in Idiopathic Intracranial Hypertension'. Together they form a unique fingerprint.

Cite this